Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 649.72B, Johnson & Johnson(JNJ) trades at $263.25. The stock has a price-to-earnings ratio of 28.97 and currently yields dividends of 2.10%.
As of 2026-07-25, Johnson & Johnson(JNJ) stock has fluctuated between $258.37 and $263.69. The current price stands at $263.25, placing the stock +1.9% above today's low and -0.2% off the high.
The Johnson & Johnson(JNJ)'s current trading volume is 6.35M, compared to an average daily volume of 8.53M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $164.23.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $164.23.
JNJ News
...
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss: PayPal’s offer. How Strip...
Key Points Johnson & Johnson's post-pandemic revenue growth has been modest, but it is now picking up steam. Oncology drugs are the key driver of this new gro...
Analyst ratings
73%
of 26 ratingsMore JNJ News
With markets on edge over aggressive AI spending by Alphabet and Tesla, rising oil prices, and higher bond yields, many investors are looking past high growth s...
Johnson & Johnson (JNJ) has moved into U.S. soft tissue robotic surgery after the FDA granted De Novo authorization for its OTTAVA Robotic Surgical System, a ta...
Johnson & Johnson announced positive topline results from the three-arm investigational Phase 3 MonumenTAL-6 study evaluating Tecvayli – teclistamab-cqyv – + Ta...
Johnson & Johnson (NYSE:JNJ) has received De Novo classification and marketing authorization from the FDA for its OTTAVA Robotic Surgical System. OTTAVA is des...
Key Points Vanguard Health Care ETF offers a lower expense ratio and higher dividend yield than Invesco Pharmaceuticals ETF Invesco Pharmaceuticals ETF has co...
The marketing clearance encompasses multiple general surgery procedures. The medical technology giant will initiate a commercial rollout with select U.S. facil...
Shares of Johnson & Johnson (JNJ) are marching higher after the healthcare company’s robotic surgery device was approved by the U.S. Food and Drug Administratio...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.